OSAM
CGEM icon

O'Shaughnessy Asset Management’s Cullinan Oncology CGEM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,912
Closed -$75K – 2739
2021
Q2 		$75K Buy
+2,912
New +$89.6K ﹤0.01% 1421

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

O'Shaughnessy Asset Management's CGEM Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of Cullinan Oncology (CGEM) in Q3 2021, closing a stake of 2,912 shares — an estimated $75K sold.

O'Shaughnessy Asset Management first reported a position in CGEM in Q2 2021 and held it in 1 quarter. The position peaked at $75K in Q2 2021. 66 funds tracked by Wall St. Rank hold CGEM as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining Cullinan Oncology position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 2,912 Cullinan Oncology shares in Q3 2021, an estimated $75K.
  • O'Shaughnessy Asset Management first reported a position in Cullinan Oncology in Q2 2021 and held it in 1 quarter.
  • O'Shaughnessy Asset Management's Cullinan Oncology position peaked at $75K in Q2 2021.
  • 66 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.